Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Status:
Terminated
Trial end date:
2004-03-18
Target enrollment:
Participant gender:
Summary
Current therapies for Stage III or Stage IV Prostate Cancer provide very limited benefit to
the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove
beneficial in the treatment of Stage III or Stage IV Prostate Cancer.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with Stage III or Stage IV Prostate Cancer.